Matthew L. Hedberg

ORCID: 0000-0002-2810-9724
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Gene expression and cancer classification
  • Head and Neck Cancer Studies
  • RNA Research and Splicing
  • Cancer Diagnosis and Treatment
  • Cancer-related gene regulation
  • Sarcoma Diagnosis and Treatment
  • PI3K/AKT/mTOR signaling in cancer
  • Molecular Biology Techniques and Applications
  • Virus-based gene therapy research
  • Cancer-related molecular mechanisms research
  • Parvovirus B19 Infection Studies
  • Cutaneous lymphoproliferative disorders research
  • Eosinophilic Disorders and Syndromes
  • Immunodeficiency and Autoimmune Disorders
  • Nonmelanoma Skin Cancer Studies
  • Mosquito-borne diseases and control
  • Peptidase Inhibition and Analysis
  • Viral-associated cancers and disorders
  • MicroRNA in disease regulation
  • Inflammatory mediators and NSAID effects
  • Genomics and Chromatin Dynamics
  • Acne and Rosacea Treatments and Effects
  • IL-33, ST2, and ILC Pathways

University of Pennsylvania
2021-2024

Government of the United States of America
2022

Federal Reserve
2022

Washington University in St. Louis
2017-2020

University of Pittsburgh
2013-2019

Eye and Ear Foundation
2019

University of Pittsburgh Medical Center
2019

Carnegie Mellon University
2013-2017

University of Utah
2010-2016

University of Michigan
2016

Genomic findings underscore the heterogeneity of head and neck squamous cell carcinoma (HNSCC). Identification mutations that predict therapeutic response would be a major advance. We determined mutationally altered, targetable mitogenic pathways in large HNSCC cohort. Analysis whole-exome sequencing data from 151 tumors revealed phosphoinositide 3-kinase (PI3K) pathway to most frequently mutated oncogenic (30.5%). PI3K pathway-mutated harbored significantly higher rate known cancer genes....

10.1158/2159-8290.cd-13-0103 article EN cc-by Cancer Discovery 2013-04-26

Abstract Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer characterized by Epstein-Barr virus (EBV) infection dense lymphocyte infiltration. The scarcity of NPC genomic data hinders the understanding biology, disease progression rational therapy design. Here we performed whole-exome sequencing (WES) on 111 micro-dissected EBV-positive NPCs, with 15 cases subjected to further whole-genome (WGS), determine its mutational landscape. We identified enrichment for aberrations...

10.1038/ncomms14121 article EN cc-by Nature Communications 2017-01-18

BACKGROUND. Recurrence and/or metastasis occurs in more than half of patients with head and neck squamous cell carcinoma (HNSCC), these events pose the greatest threats to long-term survival. We set out identify genetic alterations that underlie recurrent/metastatic HNSCC.

10.1172/jci82066 article EN Journal of Clinical Investigation 2015-11-29

Skin is composed of diverse cell populations that cooperatively maintain homeostasis. Up-regulation the nuclear factor κB (NF-κB) pathway may lead to development chronic inflammatory disorders skin, but its role during early events remains unclear. Through analysis single-cell RNA sequencing data via iterative random forest leave one out prediction, an explainable artificial intelligence method, we identified immunoregulatory for a unique paired related homeobox-1 (Prx1) + fibroblast...

10.1126/scitranslmed.abj0324 article EN Science Translational Medicine 2022-02-02

The significance of human papillomavirus (HPV) in nasopharyngeal carcinomas (NPCs) a low-incidence population remains unknown.Samples from 90 patients with NPC (years, 1957-2012) were analyzed for Epstein-Barr virus (EBV). Clinical data, EBV, HPV, and p16 status correlated overall survival (OS; 63 cases; years, 1981-2012).Of 9 HPV-positive cases, 3 extended extra-nasopharyngeal sites. Nasopharyngeal origin was confirmed 6 cases. had OS similar to EBV-positive (85 vs 141 months; p > .05)....

10.1002/hed.23318 article EN Head & Neck 2013-06-18

Aberrant activation of EGFR in human cancers promotes tumorigenesis through stimulation AKT signaling. Here, we determined that the discoidina neuropilin-like membrane protein DCBLD2 is upregulated clinical specimens glioblastomas and head neck (HNCs) required for EGFR-stimulated tumorigenesis. In multiple cancer cell lines, activated phosphorylation tyrosine 750 (Y750) DCBLD2, which located within a recently identified binding motif TNF receptor-associated factor 6 (TRAF6). Consequently,...

10.1172/jci73093 article EN Journal of Clinical Investigation 2014-07-24

Chikungunya virus (CHIKV) is an arthritogenic alphavirus that acutely causes fever as well severe joint and muscle pain. Chronic musculoskeletal pain persists in a substantial fraction of patients for months to years after the initial infection, yet we still have poor understanding what promotes chronic disease. While replicating has not been detected joint-associated tissues with persistent arthritis nor various animal models at convalescent time points, viral RNA acute infection. To...

10.1371/journal.ppat.1007993 article EN cc-by PLoS Pathogens 2019-08-29

Abstract Background Patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) demonstrate aberrant activation of the phosphotidylinositol‐3‐kinase (PI3K)/Akt/mammalian target rapamycin (mTOR) pathway. We examined efficacy everolimus, an mTOR inhibitor, in patients recurrent or metastatic HNSCC. Methods This single‐arm phase II study enrolled biomarker‐unselected HNSCC who failed at least 1 prior therapy. Everolimus was administered until progressive disease...

10.1002/hed.24501 article EN Head & Neck 2016-05-27

Type I interferons (IFNs) are key mediators of the innate immune response. Although members this family cytokines signal through a single shared receptor, biochemical and functional variation exists in response to different IFN subtypes. While previous work has demonstrated that type IFNs essential control infection by chikungunya virus (CHIKV), globally emerging alphavirus, contributions individual subtypes remain undefined. To address question, we evaluated CHIKV pathogenesis mice lacking...

10.1128/jvi.00841-19 article EN Journal of Virology 2019-10-14

PIK3CA is the most commonly altered oncogene in head and neck squamous cell carcinoma (HNSCC). We evaluated impact of nonsteroidal anti-inflammatory drugs (NSAIDs) on survival a PIK3CA-characterized cohort 266 HNSCC patients explored mechanism relevant preclinical models including patient-derived xenografts. Among subjects with mutations or amplification, regular NSAID use (≥6 mo) conferred markedly prolonged disease-specific (DSS; hazard ratio 0.23, P = 0.0032, 95% CI 0.09–0.62) overall...

10.1084/jem.20181936 article EN cc-by-nc-sa The Journal of Experimental Medicine 2019-01-25

Sarcoidosis is a multiorgan granulomatous disease that lacks diagnostic biomarkers and targeted treatments. Using blood skin from patients with sarcoid non-sarcoid granulomas, we discovered granulomas different diseases exhibit unique immune cell recruitment molecular signatures. Sarcoid were specifically enriched for type 1 innate lymphoid cells (ILC1s) B exhibited programs associated formation of mature tertiary structures (TLSs), including increased CXCL12/CXCR4 signaling. Lung...

10.1172/jci178711 article EN cc-by Journal of Clinical Investigation 2024-09-02

Previously, we reported modeling synovial sarcomas in mice by conditionally expressing the human t(X;18) translocation-derived SYT-SSX2 fusion protein Myf5-expressing myoblasts. Using a tamoxifen-inducible CreER system mice, show here that sporadic expression of across multiple tissue types leads to exclusive formation sarcoma-like tumors, whereas its widespread is lethal. Certain clinical and histologic features tumors this new model suggest additional nonmyoblast origin for sarcoma....

10.1158/0008-5472.can-08-4127 article EN Cancer Research 2009-04-08

Abstract BYL719 is a PI3K inhibitor that has demonstrated efficacy in the treatment of head and neck squamous cell carcinoma. exerts its therapeutic effect by suppressing AKT other proliferative signaling mechanisms. Despite inhibition suppression, residual activity protein S6, core marker activation, been observed. HER3, either via dimerization or activation ligand neurgeulin (NRG), known to activate PI3K. Thus, we hypothesized co-targeting HER3 would lead greater suppression PI3K-AKT...

10.1038/s41598-019-45589-y article EN cc-by Scientific Reports 2019-06-24

Synovial sarcoma (SS) is an aggressive soft-tissue that often discovered during adolescence and young adulthood. Despite the name, synovial does not typically arise from a synoviocyte but instead arises in close proximity to bones. Previous work demonstrated mice expressing characteristic SS18-SSX fusion oncogene myogenic factor 5–expressing (Myf5-expressing) cells develop fully penetrant sarcomagenesis, suggesting skeletal muscle progenitor cell origin. However, Myf5 restricted committed...

10.1172/jci94955 article EN Journal of Clinical Investigation 2017-11-19

Sarcomatoid renal cell carcinoma (sRCC) is a highly aggressive form of dedifferentiated carcinoma. We report 62-year-old man who presented with respiratory symptoms and lung mass on chest computed tomography (CT). The patient underwent positron emission tomography/computed (PET/CT) 18F-fluorodeoxyglucose (18F-FDG) was found to have extensive metastatic disease. Based the history imaging findings, there were possible primary malignancies, including bronchogenic carcinoma, melanoma, or an...

10.15586/jkcvhl.2018.99 article EN cc-by Journal of Kidney Cancer and VHL 2018-01-11

10.1016/j.jid.2021.02.761 article EN publisher-specific-oa Journal of Investigative Dermatology 2021-06-21

Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning /...

10.1001/jama.2021.16176 article EN JAMA 2021-11-09
Coming Soon ...